<?xml version="1.0" encoding="UTF-8"?>
<p id="Par85">Although a wide range of viruses can cause CNS infections, the treatment options are limited. Early treatment using acyclovir (I.V.) pending diagnosis was recommended by the CMGs focused on viral CNS infections that included treatment recommendations [
 <xref ref-type="bibr" rid="CR7">7</xref>, 
 <xref ref-type="bibr" rid="CR22">22</xref>, 
 <xref ref-type="bibr" rid="CR26">26</xref>–
 <xref ref-type="bibr" rid="CR33">33</xref>] since early treatment with acyclovir has been associated with a lower risk of sequelae and death from the most commonly diagnosed cause, HSV [
 <xref ref-type="bibr" rid="CR7">7</xref>] (Table 
 <xref rid="Tab6" ref-type="table">6</xref>). The recommended dose for adults or unspecified populations was 10 mg/kg I.V. with a recommended duration varying from 10 to more than 14 days. A CMG from France (2017) recommended the addition of amoxicillin in adults to cover for risk of 
 <italic>L. monocytogenes</italic> [
 <xref ref-type="bibr" rid="CR26">26</xref>]. The dose for children ranged from 10 to 20 mg/kg acyclovir I.V. for 14 to more than 21 days [
 <xref ref-type="bibr" rid="CR27">27</xref>, 
 <xref ref-type="bibr" rid="CR28">28</xref>], to 20 mg/kg I.V. for neonates for at least 14 days [
 <xref ref-type="bibr" rid="CR27">27</xref>, 
 <xref ref-type="bibr" rid="CR28">28</xref>, 
 <xref ref-type="bibr" rid="CR32">32</xref>]. It was noted that treatment and duration should be assessed depending on additional symptoms and modified depending on diagnostic results. 
</p>
